Octreotide Acetate Injection, Solution
Product Images NDC 71288-567

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 71288-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label Principal Display Panel (Octreotide Acetate Injection 100 mcg Carton)

Octreotide Acetate Injection 100 mcg per mL printed carton label for 10 single-dose vials. The label indicates the solution is for subcutaneous or intravenous use, labeled by Meitheal Pharmaceuticals, Inc. The packaging includes usage instructions and warnings.*

FDA Label Image

Package Label Principal Display Panel (Octreotide Acetate Injection 100 mcg Vial Label)

Label for Octreotide Acetate Injection 100 mcg per mL in a 1 mL single-dose vial, indicated for subcutaneous or intravenous use. The product is manufactured by Meitheal Pharmaceuticals, Inc., Chicago, IL, and made in China. The label includes a barcode, lot, and expiration date fields.*

FDA Label Image

Package Label Principal Display Panel (Octreotide Acetate Injection 500 mcg Carton)

Packaging label for Octreotide Acetate Injection 500 mcg per mL by Meitheal Pharmaceuticals, Inc. The label is for intravenous and subcutaneous use, containing 10 x 1 mL single-dose vials. The label displays dosage strength, administration routes, manufacturer information, barcode, and regulatory text.*

FDA Label Image

Package Label Principal Display Panel (Octreotide Acetate Injection 500 mcg Vial Label)

Label of Octreotide Acetate Injection 500 mcg per mL in a 1 mL single-dose vial. The medication is indicated for subcutaneous or intravenous use. The label includes the National Drug Code (NDC 71288-568-01) and identifies Meitheal Pharmaceuticals, Inc. as the manufacturer, based in Chicago, IL, with the product made in China.*

FDA Label Image

Package Label Principal Display Panel (Octreotide Acetate Injection 50 mcg Carton)

Packaging label for Octreotide Acetate Injection 50 mcg per mL by Meitheal Pharmaceuticals, Inc. The label indicates this is an injectable solution for subcutaneous or intravenous use, supplied in 10 single-dose 1 mL vials. The box includes detailed drug information and barcode on one panel.*

FDA Label Image

Package Label Principal Display Panel (Octreotide Acetate Injection 50 mcg Vial Label)

Label for Octreotide Acetate Injection 50 mcg per mL, an injectable solution in a 1 mL single-dose vial. Indicated for subcutaneous or intravenous use. Manufactured by Meitheal Pharmaceuticals, Inc., Chicago, IL, and made in China. Includes lot and expiration date fields.*

FDA Label Image

Structural Image (Octrotide Structure)

Chemical structure diagram of Octreotide Acetate illustrating its amino acid sequence and molecular configuration, including notation for variable component 'x' with values 1.4 to 2.5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.